This website uses cookies so that we can continually assess usage and performance. By continuing to use our site you accept our terms of use.

Close
  • Firm
  • Team
  • Portfolio
  • Network
  • Firm
  • Team
  • Portfolio
  • Network
  • News
  • Contact

Latest news
and insights

2020

PR Newswire / nference Completes $60M Series C to Accelerate and Expand Augmented Intelligence for Life Sciences

Funding broadens nference portfolio to accelerate development of novel diagnostics and therapies based on nferX™ software platform.

nference News

Celona.io / Celona Unveils the First Integrated Solution for Private Mobile Networks

New solution bridges the gap between cellular wireless and existing IT Infrastructure, enabling enterprises to build their own LTE/5G wireless networks.

Celona News

The Wall Street Journal / Digital-Health Startup Eko to Expand With $65 Million Venture Financing

Eko's Series C raise will enable Eko to expand its platform of telehealth and AI algorithms for disease screening, and launch a monitoring program for cardiopulmonary patients at home.

Eko News

The Wall Street Journal / Private 5G Networks Are Bringing Bandwidth Where Carriers Aren’t

Impatient for faster connectivity for everything from smart factories to rural broadband, companies are rolling out their own networks.

Celona News

The Washington Post / Artificial Intelligence and Covid-19: Can the machines save us?

Referred to as the 'Google of biomedicine', nference is making headlines on its efforts towards finding a vaccine for COVID-19.

nference News

Firm News / NTTVC: The Power of Partnership

I’m excited to publicly announce the launch of NTTVC and our first $500M fund. Our vision is to harness the power of partnership to offer entrepreneurs a unique model for scaling their companies.

Firm News

Press Release / NTTVC publicly announces $500 million fund created in partnership with NTT

NTTVC today publicly announced its $500 million fund to help startups reach rapid global scale by harnessing the power of partnership.

Press Release

Celona News / NTTVC Leads Series B Round

Private 5G innovator Celona announces new funding led by NTTVC and Qualcomm Ventures to expand and fuel private mobile network growth.

Celona News

Mayo Clinic / Mayo Clinic completes deidentification of expansive medical dataset

Mayo Clinic completes deidentification of expansive medical dataset to protect patient privacy, and advance research discoveries and clinical outcomes.

nference News

LinkedIn / Eko takes home the Best Hospital Diagnostics Award at the UCSF 2020 Awards

Eko took home the Best Hospital Diagnostics Award! Congratulations to Eko for leading the way and elevating cardiopulmonary care to the needs of a new era!

Eko News

Forbes / These are the startups applying AI to transform healthcare

Healthcare is perhaps the most important sector in the U.S. economy. In each of three areas, machine learning is being applied in transformative ways. This will only accelerate in the years ahead.

Eko News

Fortune / COVID-19 has spurred rapid transformation in health care. Let’s make sure it stays that way

Until there is a definitive therapy or vaccine for COVID-19, we must adapt to the virus—it won't adapt to us. Here are three ways we're using the pandemic as a springboard to reshape health care.

nference News

NetworkWorld / 5G can make for cost-effective private backhaul

While 5G use cases tend toward connecting many devices to a network, using the wireless technology for private backhaul can have a surprising amount of utility.

Celona News

BusinessCloud / Is this the end of the traditional stethoscope?

For the past month Dr Hussain Gandhi been testing the new Eko CORE digital stethoscope, which he says could have massive benefits in the wake of COVID-19 and the tragedy that took place in UK care homes.

Eko News

The Washington Post / Many with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?

New research suggests that some of us may be partially protected due to past encounters with common cold coronaviruses.

nference News

Network World / Private 5G can solve some enterprise problems that Wi-Fi can’t

Private 5G cellular deployments fit the needs of enterprises for high-speed, low-latency connections between large numbers of devices, may replace Wi-Fi in years to come.

Trends

Cardiac Rhythm News / Eko and AstraZeneca announce digital cardiovascular health partnership

Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart failure.

Eko News

New York Times / Old vaccines may stop the coronavirus. Scientists are skeptical.

Certain vaccines may provide broad protection against infections. But new research doesn’t prove these vaccines can turn back the coronavirus, experts said.

Trends

RCR Wireless News / Five verticals that are exploring the use of CBRS

Enterprise use cases of the shared Citizens Broadband Radio Service are being explored, and CBRS start-up Celona is aiming squarely at making CBRS “consumable” for enterprise IT.

Celona News

Business Wire / Eko awarded $2.7m SBIR Grant to advance clinical study

Eko has been awarded a $2.7 million Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH). The grant will help validate algorithms for screening pathologic heart murmurs and valvular heart disease.

Eko News

ComputerWorld / How Apple devices can use CBRS spectrum and private LTE connectivity in the enterprise.

Jonny Evans from ComputerWorld reviews how Apple devices can take advantage of CBRS spectrum and private LTE connectivity in the enterprise.

Celona News

Mobihealthnews / Eko lands EUA for device that helps detect coronavirus patients with cardiac complications

Early this week Eko scored a temporary Emergency Use Authorization (EUA) for its ECG low ejection fraction tool, which can be used to help clinicians spot cardiac complications associated with the novel coronavirus.

Eko News

Forbes / Digitization of healthcare and the need for augmented intelligence

This digitization of health records presents an unprecedented opportunity for their systematic synthesis across tens of millions of patients over a privacy-preserving platform.

nference News

VentureBeat / AI indicates which symptoms might be leading indicators of COVID-19

Mayo Clinic and nference, a startup developing tech that analyzes text from biomedical publications, report that they’ve used AI to isolate phenotypes characteristic of the coronavirus.

nference News

Medical Device Network / nference launches RNA-sequencing software resource to fight COVID-19

nference launches software resource that synthesises disparate single-cell RNA-sequencing data sets to assist in the fight against the coronavirus (Covid-19) pandemic.

nference News

GlobeNewswire / Celona shows simplicity of deployment for CBRS-based enterprise cellular networks

Enterprise cellular network innovator gathers all of the elements needed to support enterprise organizations, including its unique architecture, channels, and ecosystem partners.

Celona News

Genome Web / nference poised for growth following Mayo Clinic investment partnership

nference is assisting drug discovery and precision medicine as the first partner of Mayo's Clinical Data Analytics. The partnership is set to offer the startup significant growth potential.

nference News

SF Business Times / FDA clears Eko algorithms to detect heart problems

Berkeley health-tech startup Eko was granted FDA clearance today to take its algorithm for detecting atrial fibrillation to the market. The algorithm screens for atrial fibrillation and other types of heart disease caused by heart murmurs.

Eko News

Fierce BioTech / Mayo Clinic, nference launch ambitious data platform initiative

Just a week after backing its $60 million series B round, the Mayo Clinic has tapped healthcare data analytics firm nference to build out an artificial-intelligence-powered engine

nference News
  • Firm
  • Team
  • Portfolio
  • Network
  • News
  • Contact
  • Privacy Policy
  • Terms